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IL-2 exerts multiple biological activities upon binding to its specific cell surface
receptors . The IL-2 receptor (IL-2R) is composed of at least two subunits, the p55
(CD25/Tac) and the p75 glycoproteins. p55 and p75 both bind IL-2 independently
with either lowor intermediate affinity, respectively, whereasaheterodimeric receptor
composed ofp55 and p75 binds IL-2 with high affinity (1, 2) . p75 but not p55 has
been suggested to be responsible for signal transduction (1, 2) .
HumanPBLare readily activatedby IL-2 to exhibit augmented cytotoxicity against
NK-sensitive and NK-resistant target cells, which isknown as thelymphokine-activated
killer (LAK) phenomenon (3) . CD3-CD16 + NK cells are the predominant LAK
precursor and effector cells (4) . Recently, Phillips et al . (5) have directly assessed
the involvement of the p75 IL-2R in the activation of peripheral blood NK cells
by using a recently developed mAb, termed TU27, which specifically blocks IL-2
binding to the p75 IL-2R (6) .
Although TU27 mAb preferentially reacts with CD3-CD16* NK cells (5), we
have also demonstrated that peripheral blood CD8' but not CD4+ T cells exhibit
a substantial reactivity withTU27 mAb, as estimated by flow cytometry (7) . In ad-
dition, several reports have described the direct activation of restingT cells by IL-2,
and again the p75 IL-2R has been implicated in this response (8-10) . In the present
study we haveexamined the role of p75 and p55 IL-2R in rapidly inducing periph-
eral blood T cell zytolytic activity by using the mAbs abrogating IL-2 binding to
these subunits .
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Monoclonal Antibodies.
￿
TU27 mAb reacts with the p75 IL-2R and blocks IL-2 binding
to this subunit (6) . H-31 mAb reacts with the p55 IL-2R and blocks IL-2 binding to this
subunit (11) . WT31 mAb reactive with the TCR composed of CdO chains (TCRa/S) was
purchased from Sanbio (Uden, The Netherlands) . TCR81 mAb reactive with the TCR S
chain (12) was kindly provided by Dr. M . Brenner (Dana Farber Cancer Institute, Boston,
MA) . The hybridoma cells producing anti-CD3 mAb(OKT3) and anti-CD8 mAb (OKT8)
were obtained from the American Type Culture Collection (Rockville, MD) . The hybridoma
cell producing anti-nitrophenyl (NP) hapten mAb (C6-8-2) was kindly provided by Dr. T.
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Azuma (Nagoya City University, Nagoya, Japan). These mAbs were purified from ascites
by using Affi-Gel Protein A MAPSII kit (Bio-Rad Laboratories, Richmond, CA). Antibody
heteroconjugate composed ofFab fragments ofanti-CD3 and anti-NP mAbs (OKT3 x anti-
NP) was prepared as described by Brennan et al. (13). FITC-conjugated anti-CD4 (Leu 3a),
-CD8(Leu 2a), -CD16(Leu Ila), phycoerythrin (PE)-conjugated streptavidin, and unlabeled
anti-CD3 (Leu 4) were purchased from Becton Dickinson (Mountain View, CA). FITC-
conjugated antiTCRS chain (TCR&1) was purchased from T Cell Sciences (Cambridge, MA).
Cell Culture.
￿
PBMC were isolated from the blood ofhealthy donors using Ficoll-Hypaque.
After depletion ofmonocytes and B cells by adherence to plastic dishes and passage through
nylon wool, nonadherent lymphocytes were fractionated on discontinuous gradients consisting
of30, 35, 40 and 47 .517o Percoll (Pharmacia LKB Biotechnology, Tokyo,Japan), as described
(14). The high buoyant density lymphocytes isolated from the interface between 40 and 47.5 %
contained -9517o CD3*CD16- T cells, as estimated by flow cytometry. Cells (106 cells/ml)
were cultured for 18 h in RPMI 1640 medium supplemented with 10% FCS (Gibco Labora-
tories, Grand Island, NY), L-glutamine, and antibiotics in the presence or absence ofhuman
rIL-2 (generously provided by Shionogi Pharmaceutical Co., Osaka, Japan). Anti-IL-2R mAbs
were added to the cultures 30 min before adding rIL-2.
Cytotoxicity Assays.
￿
Cytotoxicity was measured in a standard 4-h 5'Cr-release assay. In all
experiments, a graded number of effector cells were added to 104 "Cr-labeled target cells.
In some experiments, target cells were modified with NP as described (15). AntiTCR/CD3
mAbs and antibody heteroconjugate were added to the effector/target mix to a final concen-
tration of 5 Wg/ml.
Immuno. luorescence and Flow Cytometry.
￿
Immunofluorescence and flow cytometric analysis
were performed as described (16). Samples were analyzed on a FACScan (Becton Dickinson)
and data were processed by using the Consort 30 program.
Results and Discussion
Cytotoxic T cells can be directed to lyse incompatible target cells in the presence
of antiTCR/CD3 mAbs either when the target cells bear receptor for Fc portion
of the mAbs (17) or when the mAbs are crosslinked to an appropriate anti-target
cell antibody (18). To examine potential cytolytic activities induced in peripheral
blood T cells after briefexposure to IL-2 regardless of their target specificity, we
used a heteroconjugate antibody composed of Fab fragments of anti-CD3 and anti-
NP hapten mAbs (OKT3 x anti-NP), and cytotoxicity was tested against a NP-
modified murine T lymphoma EL-4. As previously described by Perez et al. (19),
peripheral blood T cell cytotoxicity assessed by this system could be rapidly aug-
mented by exposure to IL-2 in a dose-dependent manner (Fig. 1 A).
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IL-2-induced cytolytic activity in periph-
eral blood T cells. PBMC were cultured
with various concentrations (A) or 100
U/ml (B) ofrIL-2 in the presence or ab-
sence(O) of 10 hg/ml (A) or various con-
centrations (B) of H-31 ("), TU27 (A),
or both H-31 and TU27 (/) mAbs for
18 h. Then the cytotoxicity was tested
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against NP-modified EL-4 in the presence
of OKT3 x anti-NP heteroconjugate at
an E/T ratio of 5 :1 . Open triangle (B) in-
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modified EL-4 was negligible (<3%).Toestimate the involvement ofp55 and p75 IL-2R inthisrapid induction ofcyto-
toxicity in circulating T cells, cytotoxicity was tested after culturing PBMC with
rIL-2 in the presence ofH-31 and/or TU27 mAbs. TU27 mAbdramaticallyinhibited
the induction ofperipheral blood T cell cytotoxicity in a broad range of IL-2 con-
centrations (Fig. 1 A) and in a dose-dependent manner (Fig. 1 B). Although H-31
mAb alone had little effect on the IL-2-induced cytotoxicity, the combination with
TU27 inhibited the response more efficiently than did TU27 alone (Fig. 1 A, B).
Essentially identical results were obtained with PBMC isolated from five different
blood donors regarding the effect ofTU27; however, a small but significant inhibi-
tion was observed with H-31 alone in some cases, as shown in Fig. 1 A.
Wenext examined the involvementofp55 andp75 IL-2Rin inducingcytotoxicity
in T cell subpopulations. Human PBL contain two distinct types ofT cellsbearing
either TCRa//3 or TCR-y/S (19). Among TCRa/0-bearing T(Tao) cells, CD8`
T cells include the precursors ofclassical cytotoxic T cells and have been reported
to be responsible for the anti-CD3-targeted cytotoxicity in peripheral blood T cells
(19). TCR-y/6-bearing T(Tyb) cellsin PBL predominantlylackCD4 and CD8 and
exhibit MHC-unrestricted cytotoxicity afterculturingwith IL-2 (20). Afterculturing
high buoyant density PBL (N95% CD3+CD16- T cells) with rIL-2, cytotoxicity was
tested against amurine mastocytoma P815 bearingFcR formurine IgGI in the pres-
ence ofanti-CD3(Leu4,IgG1), antiTCRa/(3(WT31,IgG1), orantiTCRy/S (TCR6-1,
IgG1) mAbs. As shown in Fig. 2, substantial levels ofcytotoxicity were induced in
both Tao and Tyb cells after exposure to IL-2. A prior depletion ofCD8+ cells from
high density Tcellsby treatmentwith OKT8 mAb and complement totally abrogated
the IL-2-induced cytotoxicity in TuO cells but not in T-yb cells (data not shown),
indicating that the cytotoxic precursor in Tao cells are CD8+, as described previ-
ously (19). The IL-2 responses of both Too and Tyb cells, assessed in this system,
were almost completely blocked by TU27 mAb and also partially blocked by H-31
mAb (Fig. 2). These results clearly indicate that the p75 IL-2R expressed on CD8+
Ta/3 and T-yb cells are predominantly responsiblefor direct activation ofthese cells
by IL-2 and also demonstrate a minorbutsignificant contribution ofthep55 IL-2R.
The expression of functional IL-2R on peripheral blood T cell subpopulations,
revealed asabove, wasconfirmedby immunofluorescent stainingwith H-31 andTU27
mAbs in flow cytometric analysis (Fig. 3). As demonstrated previously (5, 7), CD16+
NK cells and CD8+ T cells express the p75 but not p55 IL-2R. TCRS-l+ T cells
express the p75 IL-2R at an intermediate levelbetweenthoseexpressed on NK and
CD8+ T cells. Essentially identical patterns ofp75 expression were consistently ob-
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FIGURE 2.
￿
Effectsofanti-IL-2R mAbs on IL-2-induced
cytolytic activities in TCRa/S- or TCR-y/6bearing T cells.
High buoyant density PBL were cultured with or without
(EI) 100U/ml of rIL-2 in the presence or absence (®) of
H-31 (M), TU27 (®), or the both H-31 and TU27 (®)
mAbs (10 Wg/ml each). After 18-h cultures, the cells were
harvestedandtheircytolytic ability wastested againstamu-
rine mastocytoma P815 bearing FcR for murine IgGl in
the presence or absence of anti-CD3(Leu 4, IgGl), anti-
TCRa/14(WT31, IgGl), or anti-TCR,y/d (TCR81, IgGl)
mAbs, as indicated, at an E/Tratioof20:1 . Basalcytotoxity
against P815 in theabsence of antiTCR/CD3 mAbs were
negligible (<5%) in all samples.1448
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FIGURE 3.
￿
Expression of thep55 and p75 IL-
2R on Tcell subpopulations. PBMC were stained
with combinations ofbiotin-conjugated H-31 or
TU27 mAbs and FITC-conjugated anti-CD16
(Leu Ila), -CD4(Leu 3a), -CD8(Leu 2a), or
TCRS chain(TCR&1)mAbs. Biotin-conjugated
mAbs were detected by using PE-conjugated
streptavidin. Sampleswere analyzed on a FAC-
CD 8+ T Cells
￿
Scan. Electronic gateswere seton CD16*, CD4+,
CD86 *h", or TCRS-1+ (i.e., FITC-stained)lym-
phocytes, respectively as indicated, at the time
of data acquisition, andhistograms were gener-
ated with redfluorescence (PE staining)of5,000
cells (solidlines).Dotted linesindicate background
staining of similarly gated subpopulations with
biotin-conjugated control IgGI mAb.
TCR& -1+ T Cells
served with TyS cells from five donors, although TyS cells from some donors con-
tained a subpopulation expressing also very low levels of the p55 IL-2R as repre-
sented in Fig. 3. Recently, Aribia et al. have demonstrated a similar level of p55
and p75 IL-2R expression in circulating NK and T cells, as estimated by
1251_
labeled IL-2 binding (10). The very low level of high affinity receptor expression
inperipheral bloodT cellsdescribed by themmaybe responsible forthe minorcon-
tribution of p55 IL-2R observed in Fig. 2, although it was hardly detectable on
CD8+ T cells in our flow cytometric analysis. In summary, our present results
directly indicate that the p75 IL-2R is predominantly responsible for direct activa-
tion ofperipheral blood T cells by IL-2 and is functional in inducing cytotoxic ac-
tivity in CD8` Tot/3 and TyS cells as well as in NK cells.
Summary
By using mAb and flow cytometry, a constitutive expression of the p75 IL-2R
was revealed in human peripheral blood CD8+ T cells and TCR6-1+ T cells as well
as in CD16+ NK cells. Anti-p75 IL-2R mAb almost completely inhibited the in-
duction ofcytolytic activity in these T cells by briefexposure to IL-2, as estimated
byantiTCR/CD3 mAb-targeted cytotoxicity. Whileanti-p55 IL-2RmAb alone in-
hibitedtheresponse only modestly, maximal inhibition wasachieved bycombiningYAGITA ET AL.
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both anti-p55 and anti-p75 IL-2R mAbs. These results indicate that the p75 IL-2R
constitutively expressed on peripheral blood CD8+ T cells and TCRS-1 + T cells is
predominantly responsible for the direct activation- of these cells by IL-2.
We thank Drs. T. Azuma and M. Brenner for mAbs; and M. Wakita for help in preparation
of the manuscript.
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